Results 181 to 190 of about 299,280 (207)

Increased Prevalence of Coronary Ectasia in Heterozygous Familial Hypercholesterolemia

Circulation, 1995
Background Although coronary atherosclerosis most commonly produces clinical effects as a result of stenosis, aneurysmal disease also occurs. We have found an increased prevalence of ectasia and aneurysmal disease in familial hypercholesterolemia (FH) suggesting a link between plasma lipoproteins and coronary aneurysms.
K, Sudhir, T A, Ports, T M, Amidon, J J, Goldberger, V, Bhushan, J P, Kane, P, Yock, M J, Malloy   +7 more
openaire   +2 more sources

Stress testing response in women heterozygous for familial hypercholesterolemia

International Journal of Cardiology, 2007
We evaluated 62 exercise treadmill tests (ETTs) in equal numbers of heterozygous for familial hypercholesterolemia (hFH) and healthy (HLY) women, matched for age, baseline systolic and diastolic blood pressure (BP) and baseline heart rate (HR), using the Bruce protocol.
Genovefa D, Kolovou, Dimitris S, Damaskos, Katherine K, Anagnostopoulou, Klelia D, Salpea, Athanasios, Dritsas, Vasiliki, Giannakopoulou, Ioannis K, Vasiliadis, Dennis V, Cokkinos   +7 more
openaire   +2 more sources

Treatment of children with heterozygous familial hypercholesterolemia

International Journal of Cardiology, 2020
Željko, Reiner, Amirhossein, Sahebkar
openaire   +2 more sources

Heterozygous familial hypercholesterolemia

Atherosclerosis, 1979
C. Gagné, S. Moorjani, D. Brun, M. Toussaint, P.-J. Lupien   +4 more
openaire   +1 more source

Refractory Hypercholesterolemia in Heterozygous Familial Hypercholesterolemia Treated with Evinacumab

Journal of Clinical Lipidology, 2023
Tiffany Haynes, Laura Grace Kukuc, Robert Fishberg   +2 more
openaire   +1 more source

[Colestipol in the treatment of heterozygous familial hypercholesterolemia].

Casopis lekaru ceskych, 1992
In the specialized clinic for disorders of the lipid metabolism 27 patients, 8 men and 19 women, heterozygotes with familial hypercholesterolaemia were treated for 8 weeks with Colestid (colestipol bags a 5 g, Upjohn, Belgium). The administered dose was 15 g colestipol per day. After colestipol treatment the authors recorded a statistically significant
R, Ceska, J, Sobra, H, Toschnerová, J, Traurig   +3 more
openaire   +1 more source

Unveiling Compound Heterozygous Familial Hypercholesterolemia

Journal of Clinical Lipidology, 2022
Daniel Soffer, Sohil Golwala
openaire   +1 more source

iPhone apps for heterozygous familial hypercholesterolemia

Journal of Clinical Lipidology, 2013
Ian G, Thomas, Kristian J, Kiraly, Gregory S, Thomas   +2 more
openaire   +2 more sources

Skin manifestations in familial heterozygous hypercholesterolemia:

2009
Familial hypercholesterolemia, a form of primary hyperlipoproteinemia, is an autosomal dominant disorder characterized by an increase in serum LDL cholesterol concentrations. Multiple types of xanthomas occur, such as tendinous, tuberous, subperiosteal, and xanthelasma.
Pietroleonardo, Lucia, Ruzicka, Thomas
openaire   +1 more source

Heterozygous familial hypercholesterolemia in the clinical management

Atherosclerosis, 2023
N.T. Kim, M.N. Nguyen, D.L. Do, T.T. Le, H.A. Le, T.H. Truong   +5 more
openaire   +1 more source